Walczak J - Search Results

1

Pharmacokinetic study of trimetrexate in combination with cisplatin.

Hudes GR, LaCreta F, Walczak J, Tinsley P, Litwin S, Comis RL, O'Dwyer PJ. Hudes GR, et al. Among authors: walczak j. Cancer Res. 1991 Jun 15;51(12):3080-7. Cancer Res. 1991. PMID: 1828188 Clinical Trial.

2

Phase I and pharmacokinetic study of the novel platinum analogue CI-973 on a 5-daily dose schedule.

O'Dwyer PJ, Hudes GR, Walczak J, Schilder R, LaCreta F, Rogers B, Cohen I, Kowal C, Whitfield L, Boyd RA. O'Dwyer PJ, et al. Among authors: walczak j. Cancer Res. 1992 Dec 15;52(24):6746-53. Cancer Res. 1992. PMID: 1458462 Clinical Trial.

3

Phase II study of weekly 5-fluorouracil, cisplatin and vinblastine in advanced non-small cell lung cancer.

O'Dwyer PJ, Langer CJ, Walczak J, Levy MH, Padavic-Shaller K, Hudes GR, Litwin S, Comis RL. O'Dwyer PJ, et al. Among authors: walczak j. Eur J Cancer. 1991;27(12):1589-93. doi: 10.1016/0277-5379(91)90420-i. Eur J Cancer. 1991. PMID: 1664216

4

Phase I trial of fluorouracil modulation by N-phosphonacetyl-L-aspartate and 6-methylmercaptopurine riboside: optimization of 6-methylmercaptopurine riboside dose and schedule through biochemical analysis of sequential tumor biopsy specimens.

O'Dwyer PJ, Hudes GR, Colofiore J, Walczak J, Hoffman J, LaCreta FP, Comis RL, Martin DS, Ozols RF. O'Dwyer PJ, et al. Among authors: walczak j. J Natl Cancer Inst. 1991 Sep 4;83(17):1235-40. doi: 10.1093/jnci/83.17.1235. J Natl Cancer Inst. 1991. PMID: 1714507 Clinical Trial.

5

Phase II study of amonafide (nafidamide, NSC 308847) in advanced colorectal cancer.

O'Dwyer PJ, Paul AR, Hudes GR, Walczak J, Ozols RF, Comis RL. O'Dwyer PJ, et al. Among authors: walczak j. Invest New Drugs. 1991 Feb;9(1):65-7. doi: 10.1007/BF00194547. Invest New Drugs. 1991. PMID: 2026485 Clinical Trial.

6

Phase II study of biochemical modulation of fluorouracil by low-dose PALA in patients with colorectal cancer.

O'Dwyer PJ, Paul AR, Walczak J, Weiner LM, Litwin S, Comis RL. O'Dwyer PJ, et al. Among authors: walczak j. J Clin Oncol. 1990 Sep;8(9):1497-503. doi: 10.1200/JCO.1990.8.9.1497. J Clin Oncol. 1990. PMID: 2391557

7

Phase I/pharmacokinetic study of topotecan by 24-hour continuous infusion weekly.

Haas NB, LaCreta FP, Walczak J, Hudes GR, Brennan JM, Ozols RF, O'Dwyer PJ. Haas NB, et al. Among authors: walczak j. Cancer Res. 1994 Mar 1;54(5):1220-6. Cancer Res. 1994. PMID: 8118810 Clinical Trial.

8

Phase I/pharmacokinetic/biochemical study of the nitroimadazole hypoxic cell sensitiser SR2508 (etanidazole) in combination with cyclophosphamide.

O'Dwyer PJ, LaCreta FP, Walczak J, Cox T, Litwin S, Hoffman JP, Zimny M, Comis RL. O'Dwyer PJ, et al. Among authors: walczak j. Br J Cancer. 1993 Oct;68(4):756-66. doi: 10.1038/bjc.1993.424. Br J Cancer. 1993. PMID: 8398704 Free PMC article. Clinical Trial.

9

Preservation of immune effector cell function following administration of a dose-intense 5-fluorouracil-chemotherapy regimen.

Weiner LM, Hudes GR, Kitson J, Walczak J, Watts P, Litwin S, O'Dwyer PJ. Weiner LM, et al. Among authors: walczak j. Cancer Immunol Immunother. 1993;36(3):185-90. doi: 10.1007/BF01741090. Cancer Immunol Immunother. 1993. PMID: 8439979 Free PMC article.

10

Phase II trial of PALA in combination with 5-fluorouracil in advanced pancreatic cancer.

Rosvold E, Schilder R, Walczak J, DiFino SM, Flynn PJ, Banerjee TK, Heim WJ, Engstrom PF, Ozols RF, O'Dwyer PJ. Rosvold E, et al. Among authors: walczak j. Cancer Chemother Pharmacol. 1992;29(4):305-8. doi: 10.1007/BF00685949. Cancer Chemother Pharmacol. 1992. PMID: 1537077 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

174 results

Search Page

Filters